Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nantong Liangchun Pharmaceutical is a specialized Chinese pharmaceutical company focused on the development and production of Traditional Chinese Medicine (TCM) for autoimmune and rheumatic diseases. The company was established based on the clinical research of the late TCM master Zhu Liangchun, who was renowned for his expertise in using medicinal insects to treat stubborn diseases. Its core operations include a research institute, a specialized hospital, and a GMP-certified manufacturing facility that produces proprietary formulations like Yishen Juanbi Granules. The company's products are widely used in China for treating chronic conditions such as rheumatoid arthritis, ankylosing spondylitis, and gout. By integrating clinical practice with industrial production, the company maintains a unique position in the TCM rheumatology market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nantong Liangchun Pharmaceutical.